U.S. Alimera Sciences, Comtech Telecommunications, Eli Lilly
June 25 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alimera Sciences, Comtech Telecommunications and Eli Lilly, on Tuesday.
HIGHLIGHTS
* Alimera Sciences Inc ALIM.O: Craig-Hallum cuts to hold from buy |
* Comtech Telecommunications Corp CMTL.O: Jefferies raises to hold from underperform |
* Eli Lilly LLY.N: Truist Securities raises target price to $1,000 from $892 |
* FMC Corp FMC.N: RBC cuts target price to $72 from $81 |
* Pool Corp POOL.O: Jefferies cuts target price to $300 from $355 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Adient Plc ADNT.N: Wells Fargo cuts target price to $32 from $33 |
* Adverum Biotechnologies Inc ADVM.O: Oppenheimer initiates coverage with outperform rating |
* Adverum Biotechnologies Inc ADVM.O: Oppenheimer initiates coverage with target price $25 |
* Aerovironment Inc AVAV.O: RBC raises target price to $200 from $185 |
* AES Corp. AES.N: Barclays raises target price to $23 from $20 |
* Agilent Technologies Inc A.N: BofA Global Research ups price objective to $140 from $134 |
* Albemarle Corp ALB.N: Piper Sandler cuts target price to $95 from $122 |
* Alight Inc ALIT.N: BofA Global Research cuts price objective to $9.50 from $10 |
* Alimera Sciences Inc ALIM.O: Alliance Global Partners cuts to neutral from buy |
* Alimera Sciences Inc ALIM.O: Craig-Hallum cuts target price to $5.50 from $8 |
* Alimera Sciences Inc ALIM.O: Craig-Hallum cuts to hold from buy |
* Alimera Sciences Inc ALIM.O: H.C. Wainwright cuts to neutral from buy |
* Alimera Sciences Inc ALIM.O: Maxim Group cuts to hold from buy |
* Ally Financial Inc ALLY.N: Evercore ISI raises target price to $45 from $43 |
* Alnylam Pharmaceuticals ALNY.O: Barclays raises target price to $291 from $236 |
* Alnylam Pharmaceuticals Inc ALNY.O: Bernstein raises target price to $260 from $218 |
* Alnylam Pharmaceuticals Inc ALNY.O: BofA Global Research raises price objective to $295 from $248 |
* Alnylam Pharmaceuticals Inc ALNY.O: Chardan Capital Markets raises PT to $265 from $225 |
* Alnylam Pharmaceuticals Inc ALNY.O: Citigroup raises target price to $291 from $227 |
* Alnylam Pharmaceuticals Inc ALNY.O: Evercore ISI raises target price to $260 from $210 |
* Alnylam Pharmaceuticals Inc ALNY.O: Leerink Partners raises target to $159 from $138 |
* Alnylam Pharmaceuticals Inc ALNY.O: Morgan Stanley raises target price to $250 from $164 |
* Alnylam Pharmaceuticals Inc ALNY.O: Needham raises target price to $275 from $200 |
* Alnylam Pharmaceuticals Inc ALNY.O: Raymond James raises target price to $242 from $208 |
* Alnylam Pharmaceuticals Inc ALNY.O: RBC raises target price to $250 from $235 |
* Alnylam Pharmaceuticals Inc ALNY.O: TD Cowen raises target price to $282 from $260 |
* Alnylam Pharmaceuticals Inc ALNY.O: Wells Fargo raises target price to $207 from $161 |
* Apple Inc AAPL.O: Evercore ISI raises target price to $250 from $220 |
* Aptiv Plc APTV.N: Wells Fargo cuts target price to $82 from $83 |
* Audioeye Inc AEYE.O: H.C. Wainwright raises target price to $23 from $17 |
* Autoliv Inc ALV.N: Wells Fargo cuts target price to $122 from $128 |
* Ball Corp BALL.N: Truist Securities raises to buy from hold; raises PT to $76 from $67 |
* Beyond Air Inc XAIR.O: BTIG cuts to neutral from buy |
* Beyond Air Inc XAIR.O: Piper Sandler cuts target price to $3.50 from $7 |
* BorgWarner Inc. BWA.N: Wells Fargo cuts target price to $44 from $45 |
* Bread Financial Holdings Inc BFH.N: Evercore ISI raises target price to $49 from $45 |
* Bridgebio pharma Inc BBIO.O: BofA Global Research cuts price objective to $42 from $50 |
* Brinker International Inc EAT.N: Stifel raises target price to $90 from $62 |
* Builders Firstsource Inc BLDR.N: Wedbush cuts target price to $175 from $215 |
* Capital One Financial Corp COF.N: Deutsche Bank cuts target price to $161 from $165 |
* Capital One Financial Corp COF.N: Evercore ISI cuts target price to $154 from $155 |
* Carpenter Technology Corp CRS.N: Deutsche Bank initiates coverage with buy rating |
* Carpenter Technology Corp CRS.N: Deutsche Bank initiates coverage with target price $144 |
* Celanese Corp CE.N: Jefferies cuts target price to $155 from $170 |
* Celsius Holdings Inc CELH.O: Truist Securities initiates coverage with hold rating |
* Celsius Holdings Inc CELH.O: Truist Securities initiates coverage with target price $60 |
* Chewy Inc CHWY.N: Jefferies raises target price to $31 from $26 |
* Citizens Financial CFG.N: Evercore ISI raises target price to $39 from $38 |
* Clearside Biomedical Inc CLSD.O: Oppenheimer initiates coverage with outperform rating |
* Clearside Biomedical Inc CLSD.O: Oppenheimer initiates coverage with target price $5 |
* Cloudflare Inc NET.N: UBS raises target price to $82 from $76 |
* Cloudflare Inc NET.N: UBS raises to neutral from sell |
* Comcast Corp CMCSA.O: Goldman Sachs initiates coverage with buy rating |
* Comerica Inc CMA.N: Evercore ISI cuts target price to $54 from $58 |
* Comtech Telecommunications Corp CMTL.O: Jefferies raises to hold from underperform |
* Core Scientific Inc CORZ.O: H.C. Wainwright raises target price to $11 from $5 |
* Corteva Inc CTVA.N: RBC cuts target price to $62 from $64 |
* Cullen/Frost Bankers Inc CFR.N: Evercore ISI cuts target price to $100 from $109 |
* Dana Incorporated DAN.N: Wells Fargo cuts target price to $12 from $13 |
* Delek US Holdings Inc DK.N: Raymond James cuts target price to $30 from $33 |
* Delek US Holdings Inc DK.N: TD Cowen cuts target price to $19 from $20 |
* Delta Air Lines Inc DAL.N: Evercore ISI raises target price to $65 from $60 |
* Dentsply Sirona Inc XRAY.O: Evercore ISI cuts target price to $28 from $35 |
* Disney DIS.N: Goldman Sachs initiates coverage with buy rating |
* Diversified Energy Company Plc DEC.N: Truist Securities initiates coverage with buy rating |
* Diversified Energy Company Plc DEC.N: Truist Securities initiates coverage with PT $18 |
* Doubleverify Holdings Inc DV.N: Morgan Stanley cuts target price to $21 from $40 |
* Doubleverify Holdings Inc DV.N: Morgan Stanley cuts to equal-weight from overweight |
* Draftkings Inc DKNG.O: Wells Fargo cuts target price to $53 from $54 |
* Eagle Materials Inc EXP.N: Jefferies cuts target price to $270 from $290 |
* eBay Inc EBAY.O: JP Morgan resumes coverage with neutral rating; price target $60 |
* eBay Inc EBAY.O: Wells Fargo raises target price to $57 from $47 |
* Elanco Animal Health Inc ELAN.N: TD Cowen raises target price to $23 from $17 |
* Eli Lilly LLY.N: Truist Securities raises target price to $1,000 from $892 |
* Enterprise Products Partners LP EPD.N: JP Morgan raises target price to $34 from $32 |
* Entrada Therapeutics, Inc. TRDA.O: H.C. Wainwright cuts target price to $18 from $20 |
* Envista Holdings Corp NVST.N: Evercore ISI cuts target price to $19 from $24 |
* Etsy Inc ETSY.O: Wells Fargo cuts target price to $56 from $58 |
* Euronet Worldwide Inc EEFT.O: Evercore ISI adds stock to its tactical outperform list |
* Euronet Worldwide Inc EEFT.O: Evercore ISI raises target price to $140 from $138 |
* Eversource Energy ES.N: BofA Global Research raises to neutral from underperform |
* Exxon Mobil Corp XOM.N: UBS raises target price to $154 from $152 |
* Fifth Third Bancorp FITB.O: Evercore ISI cuts target price to $41 from $42 |
* First Hawaiian Inc FHB.O: Wells Fargo cuts target price to $18 from $20 |
* First Horizon Corp FHN.N: Evercore ISI cuts target price to $17.5 from $18.5 |
* Fiserv Inc FI.N: Evercore ISI adds stock to its tactical outperform list |
* FMC Corp FMC.N: RBC cuts target price to $72 from $81 |
* Fox Corp FOXA.O: Goldman Sachs initiates coverage with buy rating |
* Freshpet Inc FRPT.O: Oppenheimer raises target price to $155 from $135 |
* Ftai Aviation Ltd FTAI.O: Jefferies initiates coverage with buy rating; PT $120 |
* G1 Therapeutics Inc GTHX.O: H.C. Wainwright cuts target price to $3 from $9 |
* G1 Therapeutics Inc GTHX.O: Needham cuts target price to $6 from $12 |
* G1 Therapeutics Inc GTHX.O: Raymond James cuts target price to $6 from $8 |
* Gap Inc GPS.N: TD Cowen raises target price to $30 from $28 |
* Gap Inc GPS.N: TD Cowen raises to buy from hold |
* General Motors Co. GM.N: Wells Fargo raises target price to $32 from $30 |
* GMS Inc GMS.N: D.A. Davidson cuts target price to $97 from $105 |
* Gossamer Bio Inc GOSS.O: Oppenheimer initiates coverage with outperform rating; PT $9 |
* Halozyme Therapeutics Inc HALO.O: Benchmark raises target price to $60 from $50 |
* Helix Energy Solutions Group Inc HLX.N: TD Cowen raises target price to $16 from $15 |
* Henry Schein Inc HSIC.O: Evercore ISI cuts target price to $75 from $79 |
* HF Sinclair Corp DINO.N: TD Cowen cuts target price to $48 from $54 |
* Humana Inc HUM.N: Morgan Stanley initiates coverage with equal-weight rating; PT $374 |
* Huntington Bancshares Inc HBAN.O: Evercore ISI cuts target price to $15 from $16.5 |
* Interpublic Group of Companies Inc IPG.N: BofA Global Research cuts price objective to $37 from $38 |
* Ionis Pharmaceuticals IONS.O: BofA Global Research ups price objective to $64 from $62 |
* Ionis Pharmaceuticals IONS.O: Piper Sandler raises target price to $65 from $63 |
* Keros Therapeutics Inc KROS.O: Oppenheimer initiates coverage with outperform rating |
* Keros Therapeutics Inc KROS.O: Oppenheimer initiates coverage with target price $102 |
* Keycorp KEY.N: Evercore ISI cuts target price to $16.5 from $17.5 |
* Lear Corporation LEA.N: Wells Fargo cuts target price to $132 from $139 |
* Liquidia Corp LQDA.O: Oppenheimer initiates coverage with perform rating |
* M&T Bank Corp MTB.N: Evercore ISI raises target price to $168 from $157 |
* Marathon Petroleum Corp MPC.N: Raymond James cuts target price to $220 from $230 |
* Marathon Petroleum Corp MPC.N: TD Cowen cuts target price to $184 from $210 |
* Marqeta Inc MQ.O: Wells Fargo raises to overweight from equal weight |
* Martin Marietta Materials Inc MLM.N: Jefferies cuts target price to $660 from $695 |
* McKesson Corp MCK.N: BofA Global Research raises price objective to $670 from $590 |
* Monster Beverage Corporation MNST.O: Wells Fargo cuts target price to $59 from $65 |
* Nano Nuclear Energy Inc NNE.O: Benchmark raises target price to $39 from $15 |
* Norfolk Southern Corp NSC.N: Wells Fargo cuts target price to $260 from $270 |
* Norfolk Southern Corporation NSC.N: Wells Fargo cuts target price to $260 from $270 |
* Ollie'S Bargain Outlet Holdings Inc OLLI.O: Piper Sandler raises PT to $107 from $100 |
* Owens & Minor Inc OMI.N: Baird cuts target price to $20 from $24 |
* Owens & Minor Inc OMI.N: BofA Global Research cuts price objective to $16 from $18 |
* Owens & Minor Inc OMI.N: Leerink Partners cuts target price to $17 from $21 |
* Par Pacific Holdings Inc PARR.N: TD Cowen cuts target price to $36 from $42 |
* Paramount Global PARA.O: Goldman Sachs initiates coverage with sell rating |
* Parsons Corp PSN.N: Stifel raises target price to $97 from $95 |
* PBF Energy Inc PBF.N: TD Cowen cuts target price to $37 from $45 |
* Penn Entertainment Inc PENN.O: Raymond James cuts to market perform from outperform |
* Phillips 66 PSX.N: Raymond James cuts target price to $157 from $160 |
* Pinterest Inc PINS.N: Wells Fargo raises target price to $49 from $48 |
* PNC Financial Services Group Inc PNC.N: Evercore ISI raises target to $184 from $180 |
* Pool Corp POOL.O: BofA Global Research cuts price objective to $290 from $338 |
* Pool Corp POOL.O: Jefferies cuts target price to $300 from $355 |
* Pool Corp POOL.O: Stephens cuts target price to $350 from $425 |
* Pool Corp POOL.O: Wells Fargo cuts target price to $290 from $360 |
* Pool Corp POOL.O: Oppenheimer cuts target price to $356 from $416 |
* Purecycle Technologies Inc PCT.O: TD Cowen raises target price to $7.5 from $6 |
* Regions Financial Corp RF.N: Evercore ISI cuts target price to $21 from $22 |
* Regulus Therapeutics Inc RGLS.O: H.C. Wainwright raises target price to $10 from $9 |
* ResMed RMD.N: Oppenheimer cuts to perform from outperform |
* Rivian RIVN.O: Guggenheim initiates coverage with buy rating; target price $18 |
* RXO Inc RXO.N: Jefferies raises target price to $30 from $25 |
* Ryder System Inc R.N: Morgan Stanley initiates coverage with overweight rating; PT $165 |
* Sharecare Inc SHCR.O: Morgan Stanley raises target price to $1.43 from $1.00 |
* SM Energy Co SM.N: Truist Securities initiates coverage with hold rating; PT $51 |
* Solventum Corp SOLV.N: BofA Global Research cuts price objective to $60 from $70 |
* Splash Beverage Group Inc SBEV.A: Roth MKM cuts target price to $1 from $2.85 |
* Stagwell Inc STGW.O: Goldman Sachs initiates coverage with neutral rating |
* Summit Materials Inc SUM.N: Jefferies cuts target price to $56 from $60 |
* Sun Country Airlines SNCY.O: TD Cowen raises target price to $20 from $17 |
* TE Connectivity Ltd TEL.N: Wells Fargo cuts target price to $150 from $152 |
* Uber Technologies Inc UBER.N: Piper Sandler raises target price to $88 from $86 |
* US Bancorp USB.N: Evercore ISI raises target price to $48 from $45 |
* Valero Energy Corp VLO.N: Raymond James cuts target price to $195 from $200 |
* Valero Energy Corp VLO.N: TD Cowen cuts target price to $170 from $185 |
* Visteon Corp VC.O: Wells Fargo cuts target price to $107 from $108 |
* Vulcan Materials Co VMC.N: Jefferies cuts target price to $309 from $319 |
* Warner Bros Discovery Inc WBD.O: Goldman Sachs initiates coverage with neutral rating |
* Wells Fargo & Co WFC.N: Evercore ISI raises target price to $70 from $69 |
* Wolfspeed Inc WOLF.N: Canaccord Genuity cuts target price to $45 from $47 |
* Wolfspeed Inc WOLF.N: Morgan Stanley cuts target price to $23 from $26 |
* Zeta Global Holdings Corp ZETA.N: RBC initiates coverage with outperform rating; PT $20 |
(Compiled by Bengaluru Newsroom)
</body></html>Související aktiva
Poslední novinky
Zřeknutí se odpovědnosti: Subjekty skupiny XM Group poskytují služby a přístup do naší online obchodní platformy v režimu „execution-only”, což osobám umožní prohlížet a/nebo použít obsah, dostupný zde nebo prostřednictvím webové stránky, který není určený ke změně nebo šíření. Na takový přístup a použití se vždy vztahují: (i) Všeobecné obchodní podmínky; (ii) Upozornění na rizika; a (iii) Úplné zřeknutí se odpovědnosti. Takový obsah je proto poskytovaný pouze jako obecné informace. Mějte především na paměti, že obsah naší online obchodní platformy není ani žádostí, ani nabídkou vstupu do jakýchkoliv transakcí na finančních trzích. Obchodování na jakémkoliv finančním trhu zahrnuje významnou úroveň rizika pro váš kapitál.
Veškerý materiál, zveřejněný na naší online obchodní platformě, je určený pouze pro vzdělávací/informační účely a neobsahuje ani by neměl být považovaný za finanční, investiční, daňové nebo obchodní rady a doporučení, ani záznamy o našich obchodních cenách, nebo nabídku transakce s jakýmikoliv finančními instrumenty, či nevyžádadnou propagaci pro vaši osobu.
Jakýkoliv obsah třetích stran a také obsah, připravený společností XM, jako jsou názory, novinky, výzkum, analýzy, ceny, další informace nebo odkazy na webové stránky třetích stran, které jsou zobrazeny na tomto webu, jsou poskytovány v neupravené verzi jako obecný tržní komentář, a nepředstavují investiční radu. Pokud je jakýkoliv obsah uváděný jako investiční výzkum, musíte si uvědomit a přijmout, že tento obsah nebyl určený a nebyl připravený v souladu se zákonnými požadavky, vytvořenými pro podporu nezávislosti investičního výzkumu, a jako takový by měl být podle příslušných zákonů a předpisu považovaný pouze za marketingovou komunikaci. Ujistěte se, že jste si přečetli a plně rozumíte našemu Oznámení o seznámení se s riziky a investičním výzkumu, který není nezávislý, týkající se výše uvedených informací, a ke kterým lze přejít zde.
